A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...

The Board of Supervisors unanimously approved a motion from members Janice Hahn and Kathryn Barger, which, among other things ...

Latest research at the Epilepsy Society using pioneering research equipment has shown parallels between people with ...

Psychiatrist Dr Nemal Gokool supports Prime Minister Kamla Persad-Bissessar’s move to raise the legal age for marijuana use ...

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson ...

Titusville: Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

Johnson & Johnson (JNJ) said on Tuesday that it has submitted a supplemental new drug application to the U.S. Food and Drug ...

The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...

Record numbers of people are turning to AI chatbots for therapy, reports Anthony Cuthbertson. But recent incidents have uncovered some deeply worrying blindspots of a technology out of control ...

Receiving a schizophrenia diagnosis can be devastating. Many are unaware they are sick, refusing medication, temporarily unable to work, and disjointed from friends.